In vitro and in vivo killing of ocular Demodex by tea tree oil

Aims: To compare the in vitro killing effect of different agents on Demodex and to report the in vivo killing effect of tea tree oil (TTO) on ocular Demodex. Methods: Survival time of Demodex was measured under the microscope. Sampling and counting of Demodex was performed by a modified method. Resu...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of ophthalmology Vol. 89; no. 11; pp. 1468 - 1473
Main Authors Gao, Y-Y, Di Pascuale, M A, Li, W, Baradaran-Rafii, A, Elizondo, A, Kuo, C-L, Raju, V K, Tseng, S C G
Format Journal Article
LanguageEnglish
Published BMA House, Tavistock Square, London, WC1H 9JR BMJ Publishing Group Ltd 01.11.2005
BMJ
BMJ Publishing Group LTD
Copyright 2005 British Journal of Ophthalmology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims: To compare the in vitro killing effect of different agents on Demodex and to report the in vivo killing effect of tea tree oil (TTO) on ocular Demodex. Methods: Survival time of Demodex was measured under the microscope. Sampling and counting of Demodex was performed by a modified method. Results: Demodex folliculorum survived for more than 150 minutes in 10% povidone-iodine, 75% alcohol, 50% baby shampoo, and 4% pilocarpine. However, the survival time was significantly shortened to within 15 minutes in 100% alcohol, 100% TTO, 100% caraway oil, or 100% dill weed oil. TTO’s in vitro killing effect was dose dependent. Lid scrub with 50% TTO, but not with 50% baby shampoo, can further stimulate Demodex to move out to the skin. The Demodex count did not reach zero in any of the seven patients receiving daily lid scrub with baby shampoo for 40–350 days. In contrast, the Demodex count dropped to zero in seven of nine patients receiving TTO scrub in 4 weeks without recurrence. Conclusions: Demodex is resistant to a wide range of antiseptic solutions. Weekly lid scrub with 50% TTO and daily lid scrub with tea tree shampoo is effective in eradicating ocular Demodex.
Bibliography:Correspondence to: Scheffer C G Tseng MD, PhD, Ocular Surface Center, 7000 SW 97 Avenue, Suite 213, Miami, FL 33173, USA; stseng@ocularsurface.com
ark:/67375/NVC-FRX68V54-6
istex:368E07E634265C8C101FF7D5078286159B0F2924
local:0891468
href:bjophthalmol-89-1468.pdf
PMID:16234455
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence to: …Scheffer C G Tseng …MD, PhD, Ocular Surface Center, 7000 SW 97 Avenue, Suite 213, Miami, FL 33173, USA; stseng@ocularsurface.com
Proprietary interest: none
Supported in part by an unrestricted grant from Ocular Surface Research and Education Foundation, Miami, FL, USA.
ISSN:0007-1161
1468-2079
DOI:10.1136/bjo.2005.072363